Clinical trial
A Survey of High Risk Patient and Caregiver Attitudes and Beliefs Regarding the Prescription of Intranasal Naloxone Spray for Opioid Overdose
NCT04129138 is registered in ClinicalTrials.gov with M.D. Anderson Cancer Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Survey of High Risk Patient and Caregiver Attitudes and Beliefs Regarding the Prescription of Intranasal Naloxone Spray for Opioid Overdose
- Lead sponsor
- M.D. Anderson Cancer Center
- Phase
- Observational
- Overall status
- Active, not recruiting
- Start date
- July 18, 2020
- Completion date
- June 30, 2026
- Enrollment
- 182 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
caregiver, patient